Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years

Mycoses

Volumn 41, Issue 7-8, 1998, Pages 335-338

  Hoegl, L ^a,b   Thoma Greber, E ^a   Rocken M ^a   Korting, H C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Candida; Candida glabrata; Fluconazole; HIV infection; Non albicans Candida; Resistance

Indexed keywords

DIDANOSINE; FLUCONAZOLE; LAMIVUDINE; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CASE REPORT; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PERSISTENT INFECTION; PRIORITY JOURNAL; THRUSH;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; HUMAN IMMUNODEFICIENCY VIRUS; POMACANTHUS MACULOSUS;

EID: 0031774395     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1998.tb00347.x     Document Type: Article

References (16)

1. Sullivan, D., Bennett, D., Henman, M., et al. (1993) Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J. Clin. Microbiol. 31, 2114-2133.
2. Schuffendecker, I., Freydière, A., de Montclos, M. & Gille, Y. (1993) Evaluation of four commercial systems for identification of medically important yeasts. Eur. J. Clin. Microbiol. Infect. Dis. 12, 255-260.
3. NCCLS (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A.
4. Schmalreck, A. F., Kottmann, I., Ruffer, U. & Vanca, E. (1996) Empfindlichkeitsprüfungen von Hefen gegenüber Fluconazol: Vergleich der Etest-Methode mit der Mikrodilution und der Agardilution. mycoses 39 (Suppl. 2), 31-38.
5. Revankar, S. G., Kirkpatrick, W. R., McAtee, R. K. et al. (1996) Detection and significance of fluconazole resistance in oropharyngeal candidiasis in Human Immunodeficiency Virus-infected patients. J. Infect. Dis. 174, 821-827.
6. Samaranayake, L. P. (1992) Oral mycoses in HIV infection. Oral Surg. Oral Med. Oral Pathol. 73, 171-180.
7. Powderly, W. G. (1992) Mucosal candidiasis caused by non-albicans species of Candida in HIV infected patients. AIDS 6, 604-605.
8. Just, G., Steinheimer, D., Schnellbach, M., Böttinger, C., Helm, E. B. & Stille, W. (1989) Change of causative organisms under antifungal treatment in immunosuppressed patients with HIV infections. mycoses 32 (Suppl. 2), 47-51.
9. Borg-von Zepelin, M., Eiffert, H., Kann, M. & Rüchel, R. (1993) Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Göttingen, Germany. mycoses 36, 247-253.
10. Hoegl, L., Ollert, M., Korting, H. C. (1996) The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J. Mol. Med. 74, 135-142.
11. Land, G., Burke, J., Shelby, C. et al. (1996) Screening protocol for Torulopsis (Candida) glabrata. J. Clin. Microbiol. 34, 2300-2303.
12. Fidel, P. L., Cutright, J. L., Tait, L., Sobel, D. (1996) A murine model of Candida glabrata vaginitis. J. Infect. Dis. 173, 425-431.
13. Arif, S., Barkham, T., Power, E. G., Howell, S. A. (1996) Techniques for investigation of an apparent outbreak of infections with Candida glabrata. J. Clin. Microbiol. 34, 2205-2209.
14. Moyle, G., Gazzard, B. (1996) Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs 51, 701-712.
15. Warnock, D. W., Burke, J., Cope, N. J., Johnson, E. M., von Fraunhofer, N. A., Williams, E. W. (1988) Fluconazole resistance in Candida glabrata. Lancet ii, 1310.
16. Tiballi, R. N., Zarins, L. T., He, X., Kauffman, C. A. (1995) Torulopsis glabrata: Azole susceptibilities by microdilution colorimetric and microdilution broth assays. J. Clin. Microbiol. 33, 2612-2615.